SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-279400
Filing Date
2015-08-06
Accepted
2015-08-05 21:34:54
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d86512d10q.htm 10-Q 426175
2 EX-31.1 d86512dex311.htm EX-31.1 8692
3 EX-31.2 d86512dex312.htm EX-31.2 8691
4 EX-32.1 d86512dex321.htm EX-32.1 4577
  Complete submission text file 0001193125-15-279400.txt   2527547

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nktr-20150630.xml EX-101.INS 368974
6 XBRL TAXONOMY EXTENSION SCHEMA nktr-20150630.xsd EX-101.SCH 35319
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20150630_cal.xml EX-101.CAL 53785
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20150630_def.xml EX-101.DEF 83599
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20150630_lab.xml EX-101.LAB 269375
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20150630_pre.xml EX-101.PRE 177337
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 151030833
SIC: 2834 Pharmaceutical Preparations